Table 2.
A | B | 0 | AB | |
---|---|---|---|---|
Duration of stay (day) | 5 (0 - 40) 6.8 ± 5.3 | 6 (1 - 53) 8.2 ± 7.4 | 5 (1 - 59) 7.3 ± 6.3 | 5 (2 - 30) 7.2 ± 5 |
≤7 days | N = 344, 49.3% | N = 93, 13.3% | N = 203, 29.1% | N = 58, 8.3% |
>7 days | N = 117, 43.2% | N = 52, 19.2% | N = 76,28% | N = 26, 9.6% |
Age | ||||
< 65 y | 5 (0 - 32) 6.1 ± 4.2 | 5 (1 - 22) 7.1 ± 4.7 | 5 (1 - 27) 6.4 ± 4.3 | 5 (2 - 23) 6.4 ± 3.8 |
≥ 65 y | 6 (0 - 40) 8.4 ± 6.8 | 7 (1 - 53) 10.6 ± 11 | 6 (1 - 59) 9 ± 8.7 | 6.5 (2 - 30) 9.8 ± 7.2 |
Gender | ||||
Female | 5 (0 - 32) 6.5 ± 4.9 | 5 (2 - 48) 7.6 ± 6.9 | 5 (1 - 34) 7.1 ± 5.6 | 5 (2 - 17) 6.2 ± 3.4 |
Male | 5 (0 - 40) 7.2 ± 5.6 | 6 (1 - 53) 8.6 ± 7.7 | 5 (1 - 59) 7.5 ± 6.9 | 5 (2 - 30) 8.1 ± 6.1 |
Comorbidity | ||||
Yes | 5 (0 - 40) 7.6 ± 6.3 | 6.5 (1 - 53) 9.4 ± 9.4 | 6 (1 - 59) 8 ± 7.2 | 5 (2 - 23) 7 ± 4.3 |
No | 5 (1 - 26) 6.1 ± 3.8 | 5 (1 - 30) 7.2 ± 5.2 | 5 (1 - 34) 6.3 ± 4.9 | 5 (2 - 30) 7.5 ± 6 |
PCR | ||||
Positive | 5 (0 - 40) 7.9 ± 6 | 8 (2 - 48) 10.1 ± 7.6 | 6 (1 - 34) 8.5 ± 6.6 | 6 (2 - 23) 7.9 ± 4.9 |
Negative | 5 (0 - 31) 5.6 ± 4 | 5 (1 - 53) 6.3 ± 6.7 | 5 (1 - 59) 6 ± 5.7 | 5 (2 - 23) 6 ± 3.6 |
Rh | ||||
Positive | 5 (0 - 40) 6.8 ± 5.2 | 6 (1 - 53) 8.3 ± 7.6 | 5 (1 - 59) 7.4 ± 6.6 | 5 (2 - 30) 7.1 ± 4.9 |
Negative | 5 (1 - 29) 7.1 ± 5.6 | 5 (3 - 29) 7.6 ± 6.3 | 5 (1 - 30) 6.5 ± 4.4 | 5 (4 - 23) 8 ± 5.7 |
Anemia | ||||
Yes | 5 (0 - 40) 7.5 ± 6.2 | 5 (1 - 48) 8.1 ± 7.7 | 5 (1 - 59) 7.4 ± 6.9 | 5 (2 - 30) 7.3 ± 5.4 |
No | 5 (0 - 31) 6.4 ± 4.3 | 6 (1 - 53) 8.3 ± 7.2 | 5 (1 - 34) 7.2 ± 5.7 | 5 (2 - 23) 7.1 ± 4.8 |